Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

BACKGROUND: Antithrombotic guidance statements for hospitalized patients with coronavirus disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to escalate doses in high‐risk patients. To date, no clear approach exists to discriminate patients at high risk for venou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Res Pract Thromb Haemost
Main Authors: Spyropoulos, Alex C., Cohen, Stuart L., Gianos, Eugenia, Kohn, Nina, Giannis, Dimitrios, Chatterjee, Saurav, Goldin, Mark, Lesser, Marty, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Barish, Matthew A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Articles ‐ Thrombosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7938615/
https://ncbi.nlm.nih.gov/pubmed/33733028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12486
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados